HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY

HUNTSVILLE, AL

Oncologygene editingGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.7M · Provider Support and Patient Outreach in Lung Cancer Screening

Jun 2025Grant renewalJun 24, 2025Source filing (opens the source filing in a new tab)

Momentum

52no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R01 · $817k · non-dilutive
Jun 1, 2025
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SWANEY, DANIELLE L · NIA · award ends Feb 28, 2030 · Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics
NIH RePORTER · NIH RePORTER 11111785 (opens the source filing in a new tab)
Grant
R01 · $705k · non-dilutive
Aug 1, 2024
HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COCHRAN, JESSE N · NIA · award ends Apr 30, 2029 · Identification of trans-regulatory elements controlling MAPT transcription
NIH RePORTER · NIH RePORTER 11146573 (opens the source filing in a new tab)
Grant
U24 · $673k · non-dilutive
Apr 4, 2024
HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI MYERS, RICHARD M · NHGRI · award ends Jan 31, 2029 · Expansion of the Human Transcription Factor Genome-wide Binding Map Resource
NIH RePORTER · NIH RePORTER 11066483 (opens the source filing in a new tab)
Grant
R01 · $701k · non-dilutive
Jul 1, 2022
THOMAS JEFFERSON UNIVERSITY · PI MYERS, RONALD E. · NCI · award ends Jun 30, 2027 · Provider Support and Patient Outreach in Lung Cancer Screening
NIH RePORTER · NIH RePORTER 11136927 (opens the source filing in a new tab)
Trial
NA registered
Oct 1, 2014
Colorectal Cancer · COMPLETED · sponsor: Thomas Jefferson University · Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
ClinicalTrials.gov · NCT02272244 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.99name similarity 100% · shared principal investigator / founder · same city
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.28same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.7M · Provider Support and Patient Outreach in Lung Cancer Screening
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics
May 2025New grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
May 2025Trial completedSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Identification of trans-regulatory elements controlling MAPT transcription
Apr 2025Grant renewalSource (opens the source filing in a new tab)
NIH U24 · $0.7M · Expansion of the Human Transcription Factor Genome-wide Binding Map Resource
Apr 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R01 · $817k · non-dilutive

R01 · $705k · non-dilutive

U24 · $673k · non-dilutive

R01 · $701k · non-dilutive

NA registered